Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography

JAMA

Volumn 279, Issue 5, 1998, Pages 376-380

  Kaufman, Marc J ^a,b   Levin, Jonathan M ^a   Ross, Marjorie H ^a   Lange, Nicholas ^a   Rose, Stephanie L ^a   Kukes, Thellea J ^a   Mendelson, Jack H ^a   Lukas, Scott E ^a   Cohen, Bruce M ^a   Renshaw, Perry F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; VASOCONSTRICTION;

EID: 6844226211     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.5.376     Document Type: Article

References (41)

1. Substance Abuse and Mental Health Services Administration. Preliminary Estimates From the 1995 National Household Survey on Drug Abuse. Washington, DC: US Dept of Health and Human Services; August 1996. Advanced Report No. 18.
2. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562.
3. Brogan WC, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116:556-561.
4. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330: 454-459.
5. Jacobs IG, Roszler MH, Kelly JK, Klein MA, Kling GA. Cocaine abuse: neurovascular complications. Radiology. 1989;170:223-227.
6. Peterson PL, Roszler M, Jacobs I, Wilner HI. Neurovascular complications of cocaine abuse. J Neuropsychiatry Clin Neurosci. 1991;3:143-149.
7. Mody C, Miller B, McIntyre H, Cobb S, Goldberg M. Neurologic complications of cocaine abuse. Neurology. 1988;38:1189-1193.
8. Klonoff D, Andrews B, Obana W. Stroke associated with cocaine use. Arch Neurol. 1989;46:989-993.
9. Levine SR, Brust JCM, Futrell N, et al. Cerebrovascular complications of the use of the 'crack' form of alkaloidal cocaine. N Engl J Med. 1990;323: 699-704.
10. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke. 1995;26: 1114-1118.
11. Daras M. Neurologic complications of cocaine. In: Majewska MD, ed. Neurotoxicity and Neuropathology Associated With Cocaine Abuse. Washington, DC: US Dept of Health and Human Services; 1996:43-65. Publication No. (NIH) 96-4019.
12. Levine SR, Brust JCM, Futrell N, et al. A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride - a review. Neurology. 1991;41:1173-1177.
13. Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46: 1291-1296.
14. Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996;46:1741-1743.
15. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry. 1988;152:641-648.
16. Holman BL, Carvalho PA, Mendelson JH, et al. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HM-PAO and ASPECT. J Nucl Med. 1991;32:1206-1210.
17. Strickland TL, Mena I, Villanueva-Meyer J, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1993;5:419-427.
18. Levin JM, Mendelson JH, Holman BL, et al. Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. J Nucl Med. 1995;36:1211-1215.
19. Berry J, van Gorp WG, Herzberg DS, et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 1993;32:231-237.
20. Hoff AL, Riordan H, Morris L, et al. Effects of crack cocaine on neurocognitive function. Psychiatry Res. 1996;60:167-176.
21. Madden JA, Powers RH. Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci. 1990;47:1109-1114.
22. Kurth C, Monitto C, Albuquerque M, et al. Cocaine and its metabolites constrict cerebral arterioles in newborn pigs. J Pharmacol Exp Ther. 1993; 266:587-591.
23. He G-Q, Zhang A, Altura B, Altura B. Cocaine-induced cerebrovasospasm and its possible mechanism of action. J Pharmacol Exp Ther. 1994;68: 1532-1539.
24. Madden JA, Konkol RJ, Keller PA, Alvarez TA. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci. 1995;56: 679-686.
25. Horikoshi T, Fukamachi A, Nishi H, Yagi S-I, Fukasawa I. Observation of vasospasm after subarachnoid hemorrhage by magnetic resonance angiography. Neurol Med Chir (Tokyo). 1995;35:298-304.
26. Black KS, Mirsky P, Kalina P, et al. Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy. AJNR Am J Neuroradiol. 1995;16:1650-1652.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:222-223.
28. Foltin RW, Fischman MW. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther. 1991;257:247-261.
29. Teoh SK, Mendelson JH, Mello NK, et al. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation. J Clin Psychopharmacol. 1993;13:87-99.
30. Evans SM, Cone EJ, Henningfield JE. Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther. 1996;279:1345-1356.
31. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613-619.
32. Agresti AA. Categorical Data Analysis. New York, NY: John Wiley & Sons; 1990.
33. Verebey K, Gold MS. From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psychiatr Ann. 1988;18:513-520.
34. Davis SM, Andrews JT, Lichtenstein M, et al. Correlations between cerebral arterial velocities, blood flow, and delayed ischemia after subarachnoid hemorrhage. Stroke. 1992;23:492-497.
35. Sekhon LHS, Morgan MK, Spence I, Weber NC. Chronic cerebral hypoperfusion and impaired neuronal function in rats. Stroke. 1994;6:1022-1027.
36. Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci. 1991;57:73-79.
37. O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1992;18:131-144.
38. Weiss RD, Gawin FH. Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. Am J Med. 1988;85:879-880.
39. Mena I, Giombetti RJ, Miller BL, et al. Cerebral blood flow changes with acute cocaine intoxication: clinical correlation with SPECT, CT and MRI. In: Sorer H, Rapaka RS, eds. Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. Washington, DC: US Dept of Health and Human Services; 1994:161-173. Publication No. (NIH) 94-3728.
40. Wahlgren NG, Hellström G, Lindquist C, Rudehill A. Sympathetic nerve stimulation in humans increases middle cerebral artery blood flow velocity. Cerebrovasc Dis. 1992;2:359-364.
41. Hellström G, Wahlgren NG. Physical exercise increases middle cerebral artery blood flow velocity. Neurosurg Rev. 1993;16:151-156.